AI summary by TwinMind
The Race to Take Down the Greatest Insider Trader
Newsthink
19m 5s
Steven Cohen's Background & Rise
- Born middle-class family Long Island, brightest of 8 siblings
- Mastered poker in high school, taught art of making money
- Attended Wharton Business School, felt need to prove himself vs wealthy classmates
- First job at Gruntal trading firm out of college
- Made $5-10 million/year in commissions in early 20s
- Exceptional trading talent recognized by colleagues
- Early SEC scare: bought RCA shares days before General Electric takeover
- SEC investigated for insider trading, pled fifth, never charged
- Ex-wife Patricia said he panicked, feared prison
- Close call taught him to be more careful
SAC Capital Launch & Strategy
- 1992: launched SAC Capital hedge fund
- Hedge fund concept: way for rich to diversify, get stable returns
- Strategy: buy best companies, short sell poor performers
- Shorting: borrow stock, sell it, repurchase cheaper to repay loan
- Dual strategy provides hedge against market fluctuations
- SAC focused on quick trades vs long-term investing (opposite Warren Buffett)
- Performance fee: charged whopping 50% vs typical 20%
- $15 billion managed, 30% average annual returns for 20 years
- Tech boom '90s benefited SAC significantly
Competitive Edge Through Information
- Faced increased competition, hired best traders/analysts for "inside scoop"
- Technically illegal to use proprietary non-public information
- "Black Edge" like doping in cycling/steroids in baseball - everyone doing it
- Cohen was best at it, favorite sector: healthcare
Matthew Martoma & Alzheimer's Drug Case
- Hired Matthew Martoma, biotechnology specialist from Boston
- MBA from Stanford, $200K base salary + millions in bonuses
- Martoma focused on Elan Corporation & Wyeth
- Testing Alzheimer's drug Bapineuzumab ("Bappy")
- Speculated to be biggest selling drug of all time
- Connected with Dr. Sydney Gilman via matchmaking firm
- Chair of safety monitoring committee for Bappy clinical trials
- Experts compensated $1,000 per 30-minute phone call
- Gilman signed confidentiality agreement, initially refused to share confidential info
The Gilman-Martoma Relationship
- Gilman began sharing confidential information as relationship developed
- Spoke often on phone, sometimes for hours
- Gilman saw Martoma as son he lost to suicide
- Martoma capitalized on friendship to access confidential areas
- Brain swelling side effects discussed - Gilman said sign drug working
- Alzheimer's caused by beta amyloid plaque buildup
- Bappy designed to attack plaque, swelling might indicate clearing
- Martoma sent Cohen memo: conviction rating 9/10 on drug promise
- Rating system protected Cohen from employee behavior details
The $700 Million Position
- Spring 2008: Cohen built $700 million positions in Elan & Wyeth based on Martoma's advice
- Other SAC health traders skeptical, didn't understand huge positions
- Elan particularly risky as smaller company
- All during 2008 financial crisis
- When skeptical analysts approached Cohen with concerns, he accused them of "pissing on the parade"
The Critical Meeting & Information Leak
- July 2008: Dr. Gilman set to present full drug trial results at International Conference on Alzheimer's Disease, Chicago
- Martoma arranged meeting claiming to visit late uncle's grave nearby
- Met at Gilman's University of Michigan office
- Gilman showed confidential PowerPoint presentation marked "Do not distribute"
- Results disappointing: Bappy only effective for small group (those without Alzheimer's gene predisposition)
- Treatment didn't improve with higher doses
- Martoma explained market doesn't like drug helping only half population
The Massive Trade & Profit
- July 20, 2008: Martoma emailed Cohen "Is there good time to catch up? It's important"
- 20-minute phone call between them
- Next 9 days: SAC liquidated entire Elan position, almost all Wyeth position
- 17.7 million shares worth ~$700 million
- Used low visibility accounts & dark pools (anonymous private exchanges)
- Also shorted nearly 8 million shares of Elan & Wyeth
- Total profits & avoided losses: $275 million
- Ironically, SAC hired former SEC chairman to discuss insider trading with employees
Market Reaction & Aftermath
- When drug failure announced, Elan dropped from $33.75 to below $10 in 3 days
- Other SAC traders expected disaster, learned SAC had sold positions
- Dr. Gilman (recovering from cancer) surprised Martoma didn't check on him
- Martoma received $9 million bonus for drug trades
- RBC Capital Markets trader noticed unusual activity, filed regulatory complaint
Federal Investigation Begins
- 2009: arrested Raj Rajaratnam (Galleon Group founder) on securities fraud
- Wall Street Journal November 2010 article exposed investigation
- Donald Longgueuil (former SAC manager) panicked, destroyed USB/hard drives
- Threw them in garbage trucks at night
- Confessed to Noah Freeman (fellow SAC manager)
- Freeman was FBI informant wearing wire, recorded conversation
- Longgueuil pled guilty to insider trading, but didn't implicate Cohen much
Dell Case & Email Evidence
- SAC analyst John Horvath tipped by Jesse Tortora about Dell earnings disappointment
- Information chain: Dell insider → hedge fund analyst → Tortora → Horvath
- Horvath told boss Michael Steinberg: "I have secondhand read from someone at company"
- Steinberg responded: "Please be discreet"
- Steinberg shorted Dell, pocketed $1 million profit
- Cohen sold entire 500,000 share long position 2 days before earnings
- After earnings: Cohen complimented "Nice job on Dell"
- Steinberg: "Thanks. This old dog can still hunt"
- Email reached Cohen through multiple managers
Legal Defense & Convictions
- Cohen's lawyer Marty Klotz argued Cohen received thousands daily emails
- Even if seen, no clear evidence of insider trading since source unknown
- December 18, 2013: Steinberg found guilty, fainted before verdict
- Sentenced 3.5 years prison, refused to cooperate with authorities
- SAC structure described as bicycle wheel: portfolio managers as spokes, Cohen as hub
Martoma's Refusal to Cooperate
- FBI certain Martoma would flip on Cohen to avoid 10-year sentence
- Surprisingly refused to turn against Cohen
- Even after SAC fired him as "one-trick pony"
- Pled fifth, refused to incriminate self or boss
- Martoma's lawyer on SAC payroll
- Cohen admitted investing in Elan based on Martoma's advice, never specified what advice was
- Never mentioned Dr. Gilman
Trial & Sentencing
- Dr. Gilman painted as victim - lonely older man charmed by young trader
- Resigned from University of Michigan in disgrace
- Gilman said Martoma reminded him of deceased son who committed suicide
- FBI agent told Gilman: "I am only grain of sand, as is Mr. Martoma. They are really after Steven A. Cohen"
- Three theories for Martoma's silence:
- Honor (didn't want to snitch)
- Fear of retribution
- Hope Cohen would repay loyalty financially
- Martoma's father cited ninth commandment: "Thou shalt not bear false witness"
- Martoma found guilty securities fraud, sentenced 9 years prison
- Day Martoma started sentence: Cohen spent $101 million at Sotheby's on Alberto Giacometti sculpture "The Chariot"
Cohen's Outcome & Aftermath
- Never charged with insider trading
- SEC dropped insider trading charge, instead charged failure to supervise Steinberg & Martoma
- No criminal charges against Cohen personally
- SAC Capital pled guilty, paid $1.8 billion fines
- SAC agreed to stop managing outside money, convert to family office
- Could only manage personal $10 billion wealth
- SAC rebranded to Point72 Asset Management
- 2018: family office reopened to outside investors
- Last year generated $2.4 billion profit
- 2020: bought New York Mets for $2.4 billion
- Continued buying art & trading
Personal Details
- Lived in 35,000 sq ft Greenwich, Connecticut mansion
- Flew to work by helicopter
- Art collection valued $1 billion including $8 million shark suspended in formaldehyde
- Nicknamed "ultimate predator" for trading instincts
